Anorexia nervosa, bulimia nervosa and binge-eating disorder remain challenging disorders for the practicing psychiatrist. While psychopharmacological agents play an important role in the overall treatment of eating disorders, current empirical evidence does not support their sole use. A recipe consisting of evidence-based psychopharmacological agents together with evidence-based psychotherapeut...

INTRODUCTION Studies have shown a high prevalence of psychiatric illnesses among patients in primary health care settings. Family physicians have a fundamental role in managing psychiatric illness with psychopharmacological medications. Providing information about the disease, its management and the potential adverse effects of the medications is an important part of the management of mental il...

The advances made on genetic influence response and side effects of psychiatric pharmacotherapy improved the concept personalized psychiatry. current evidence suggests that testing can be useful in patients who did not respond or tolerate at least one previous pharmacotherapy. Approximately 90% all drugs are metabolized by only few different cytochrome enzymes. Pharmacogenetic research has prov...

PURPOSE To evaluate pathways through which sociodemographic, clinical, attitudinal, and perceived health control variables impact psychiatric patients' adherence to psychopharmacological medications. METHOD A sample of 966 consecutive psychiatric outpatients was studied. The variables were sociodemographic (age, gender, and education), clinical (diagnoses, drug treatment, and treatment durati...

PSYCHOPHARMACOLOGICAL TREATMENT OF DEPRESSION Correct diagnosis, cooperation of the patient, right dosage and the obsevation of the efficacy of the drug on the therapeutic improvement of the patient are always good means in reaching a successive treatment. As well as it is important for the clinican to have a precise knowledge of the disorder, it is as important for him to acquire the knowledge...